Dentsply Sirona CEO Don Casey leaves

  • Push-out Score determined
  • After about four years in the position
  • Praise, thanks and good wishes for Casey
  • John Groetelaars taking over temporarily
  • Search for a successor

(exechange) — Charlotte, North Carolina, April 19, 2022 — Don Casey, chief executive of Dentsply Sirona, leaves. As announced by Dentsply Sirona Inc. in a news release on Tuesday, April 19, 2022, Donald M. (Don) Casey leaves his post as chief executive officer at the manufacturer of professional dental products, after about four years in the role, effective immediately.

Dentsply Sirona will undertake a search for a successor.

Don Casey’s duties as CEO will be taken over temporarily by John P. Groetelaars, most recently Chief Executive Officer at Hill-Rom Holdings, Inc., as Interim Chief Executive Officer.

Already a director

Groetelaars is already a director of Dentsply Sirona. Generally speaking, most director-turned-CEO appointments occur following a sudden resignation of the outgoing CEO and signal a lack of preparedness on the company’s part to groom internal talent. Directors-turned-executives represent a blend of outsider and insider.

They don’t have the constraints of a pure insider when it comes to leading painful changes or making unpopular decisions, and they have more company knowledge than a pure outsider.

Having been a director, Groetelaars understands the expectations and dynamics of the board and has knowledge of Dentsply Sirona’s organization, risk-management practices and strategy.

“We are focused on finding a candidate with a track record of world-class execution and operational expertise”

Dentsply Sirona did not give an explicit reason for Don Casey’s departure from the CEO post. Eric Brandt, Non-Executive Chairman of the Board, said: “As the Board conducts its search for a permanent CEO, we are focused on finding a candidate with a track record of world-class execution and operational expertise who can position the Company for the future.”

Precise information regarding Don Casey’s future plans was not immediately available.

“Terminated”

Dentsply Sirona said: “DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced the appointment of John Groetelaars, who serves on Dentsply Sirona’s Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO and will cease to serve as a member of the Company’s Board, effective immediately.”

Share price decline since February 2018

The announcement follows a decline in Dentsply Sirona Inc.’s share price of 20% since February 2018. February 2018 is the month in which Casey’s tenure as CEO began.

In the position of CEO since 2018

Don Casey became CEO of the Company in 2018.

Casey has served as the Company’s Chief Executive Officer since February 2018.

Casey served from 2012 through 2018 as the Chief Executive Officer of the Medical Segment of Cardinal Health, a manufacturer and provider of medical products and supply chain services.

From 2010 to 2012, Casey served as Chief Executive Officer of the Gary and Mary West Wireless Health Institute, a non-profit research organization focused on lowering the cost of health care through novel technology solutions.

Prior to that, Casey served from 2007 to 2010 as Worldwide Chairman for Johnson & Johnson’s Comprehensive Care group and as a member of the Executive Committee.

Prior to that, from 2003 to 2006, Casey served as Company Group Chairman with Vistakon, a division of Johnson & Johnson Vision Care, Inc., and from 1985 to 2003, Casey held various executive positions throughout Johnson & Johnson’s consumer, pharmaceutical and medical device franchises.

Casey also served as a director of West Corporation from 2015 to 2017.

Push-out Score determined

The Push-out Score™ determined by exechange gauges the pressure surrounding Don Casey’s move on a scale of 0 to 10.

exechange reached out to Dentsply Sirona and offered the company the opportunity to comment on the score.

Read the full story in the exechange report 17.2022 ($).